-
Guardant and IQVIA Develop Precision Oncology Platform to Normalize Clinical Data
Clinical Research News | Innovative Practices Award | Extracting high-quality data from clinical records can be time-consuming and costly, primarily when manual abstractors are tasked with mining complex, unstructured, and lengthy documents. That’s why the scientists at Guardant Health and Linguamatics, an IQVIA company, launched a real-world evidence database called GuardantINFORM. The platform was named one of the 2022 Bio-IT World Innovative Practices award winners.
Jun 2, 2022
-
Chasing Digital Twins: Pilot Project Tackles Cancer Patient Twins in Neuro-Oncology
Clinical Research News | At the Bio-IT World Conference & Expo last month, a team of researchers reported on their 12-week pilot effort to build cancer patient digital twins to aid in oncologist decision-making.
Jun 1, 2022
-
World’s First Clinical Trials Ecosystem and Marketplace About To Open
Clinical Research News | As the world’s first clinical trial ecosystem and marketplace, ClinEco—launching in beta this summer—is designed to connect study sponsors in need of clinical trial support with the full range of clinical trial technology and service providers.
May 31, 2022
-
Unleashing the Value of Study Data with Digital Health Technology
Clinical Research News |In recent years, a slew of digital health technologies (DHTs), designed to collect and share data remotely, have emerged to capture more data from clinical trials. And while uptake has been slow, new guidelines and regulations from the United States and European Union are finally creating a practical framework for an operation that promises to shift the dial. But do we finally have the structures we need to build 21st-century clinical trials that hasten access to life-saving treatments? Or is there more we could be doing with data?
May 27, 2022
-
Cloud-Based Registry for HIV Clinical Study, Next-Gen Gene and Cell Therapy Research, More
Clinical Research News | NIAID awards $577 million to establish nine Antiviral Drug Discovery Centers; Allelica and Invitae build clinical artificial intelligence architecture for breast cancer; a new COVID-19 antibody test is used in vital pandemic research; next-generation gene and cell therapy research promote more efficient clinical trials; and more.
May 26, 2022